Halo Labs Analysis: $13M Raised
What is Halo Labs?
Halo Labs specializes in particle analysis technology for biotherapeutic development. Their innovative approaches, including Backgrounded Membrane Imaging and Fluorescence Membrane Microscopy, enhance the accuracy and speed of particle identification. This technology accelerates decision-making in drug development and manufacturing processes, ensuring safety and quality in biotherapeutics.
HQ Country
Burlingame, United States
Employees
11-50
Industry
Biotech, HealthTech, Data Analytics
Product Features & Capabilities
- Aura particle analyzers for various therapeutic workflows
- Backgrounded Membrane Imaging technology for comprehensive particle analysis
- Fluorescence Membrane Microscopy for particle identification
- Aura PTx for protein and antibody therapeutics
- Aura GT for gene therapy workflows.
How much Halo Labs raised
Series C - $6 million
July 11, 2022Lead Investor: Agilent Technologies Inc., Research Corporation Technologies, Broad Oak Capital Partners, BioAdvance
